Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $154,627 - $168,730
1,062 Added 23.83%
5,518 $864,000
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $294,211 - $329,592
1,889 Added 73.59%
4,456 $694,000
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $396,216 - $426,404
2,567 New
2,567 $424,000
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $133,936 - $149,170
-875 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $2.32 Million - $2.66 Million
-16,910 Reduced 95.08%
875 $138,000
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $19.9 Million - $21.8 Million
-141,777 Reduced 88.85%
17,785 $2.65 Million
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $462,427 - $558,280
-3,590 Reduced 2.2%
159,562 $22.4 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $4.19 Million - $5.81 Million
-37,733 Reduced 18.78%
163,152 $21.4 Million
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $2.19 Million - $2.51 Million
-17,138 Reduced 7.86%
200,885 $29.3 Million
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $1.23 Million - $1.38 Million
9,727 Added 4.67%
218,023 $28.2 Million
Q2 2019

Aug 12, 2019

SELL
$131.15 - $144.24 $972,870 - $1.07 Million
-7,418 Reduced 3.44%
208,296 $29 Million
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $817,557 - $909,054
6,503 Added 3.11%
215,714 $30.2 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $3.17 Million - $3.81 Million
-25,792 Reduced 10.98%
209,211 $27 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $1.07 Million - $1.26 Million
8,793 Added 3.89%
235,003 $32.5 Million
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $2.01 Million - $2.22 Million
16,860 Added 8.05%
226,210 $27.4 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $3.21 Million - $3.8 Million
25,628 Added 13.95%
209,350 $26.8 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $24.1 Million - $26.4 Million
183,722
183,722 $25.7 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $377B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Partners Capital Investment Group, LLP Portfolio

Follow Partners Capital Investment Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Partners Capital Investment Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Partners Capital Investment Group, LLP with notifications on news.